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Background: Mupirocin ointment has been shown to be effective in eradicating 
Staphylococcus aureus nasal carriage in residents of a long-term care facility. Antiseptic 
soaps have been used as adjunct to this therapy. We compared the efficacy of short-term 
intranasal mupirocin ointment with and without chlorhexidine baths in the eradication 
of S. aureus nasal carriage with follow-up for 12 weeks. 
Methods: Residents in four nursing homes known to have endemic methicillin-resistant 
S. aureus were screened for nasal carriage of S. aureus. Residents who had anterior 
nares cultures positive for S. aureus on two separate occasions were divided into two 
groups. Both groups received intranasal mnpirocin ointment twice daily for 5 days and 
one group also received chlorhexidine baths for the first 3 days. Cultures of anterior 
nares, axilla, and groins were performed before treatment and 1 day and 1, 4, 8, and 12 
weeks after treatment. 
Results: After treatment, S. aureus nasal carriage was eradicated in all residents. 
Recolonization with S. aureus had occurred at 12 weeks in 24% of residents receiving 
mupirocin ointment alone (6/25) and in 15% of residents receiving mnpirocin ointment 
plus ch]orhexidine baths (4/27). 
Conclusions: A short course of mupirocin ointment was effective in eradicating nasal 
carriage of S. aureus in nursing home residents. There were no statistical differences in 
efficacy between the two regimens with respect to the eradication ofnasal carriage and 
prevention of recolonization with S. aureus. (AJIC AM J INFECT CONTROL 1995;23: 
306-9) 
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Some res idents  in  nurs ing  homes  are nasa l  
car r iers  of Staphy lococcus  aureus ,  which  may be 
meth ic i l l i n  suscept ib le  (MSSA) or rneth ic i l l in  re- 
s is tant  (MRSA). MRSA nasa l  car r ie rs  in a long- 
te rm care faci l i ty have been found to have staphy- 
lococcal  in fect ions  more  f requent ly  than  noncar -  
riers.1 Moreover ,  MRSA nasa l  car r ie rs  in  nurs ing  
homes  are reservo i rs  for MRSA when they are 
t rans fer red  to acute care hospitals.  2'3 
Through the years,  e rad icat ion  of S.  aureus  
nasa l  car r iage  has been  a t tempted  wi th  systemic 
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and topical antimicrobial agents, with varying 
degrees of success .  4"6 Mupirocin ointment has 
been used with success to treat nursing home 
residents for nasal carriage, but recolonization 
occurs. 78 To eradicate S. aureus  carriage on other 
parts of the body, which may be the source of 
recolonization, we applied intranasal mupirocin 
ointment and gave chlorhexidine baths to patients 
undergoing long-term hemodialysis who were 
S. aureus  nasal carriers, with good success .  9 The 
purpose of this investigation was to compare the 
efficacy of intranasal mupirocin ointment alone 
with that of the combination of intranasal mupi- 
rocin ointment and chlorhexidine baths in the 
eradication of S. aureus  nasal carriage in residents 
of nursing homes. 
METHODS 
Patient population 
Nursing homes in the greater Youngstown area 
with MRSA colonization known to be endemic 
among their residents were contacted. The ra- 
tionale for doing the study was explained to the 
administrators or directors of nursing to seek 
their approval for participation in this study. The 
nursing homes incurred no cost for the study. We 
provided the medications and performed all the 
cultures. One of us (C. A.) gave in-service pro- 
grams and provided written instructions to the 
nursing home staff regarding proper application 
of mupirocin ointment o the anterior nares and 
proper bathing of the whole body with chlo- 
rhexidine from the neck down, with special at- 
tention to the axillary and groin areas. Permis- 
sion was obtained from attending physicians to 
talk to residents under their care regarding this 
study. Written informed consent was obtained 
from all residents who volunteered for the study. 
The research protocol was approved by the medi- 
cal research committee and the institutional re- 
view board of St. Elizabeth Hospital Medical 
Center. 
Screening of residents 
Written informed consent was obtained from 
all residents who were older than 18 years, were 
not pregnant, and had no history of allergy to 
mupirocin or chlorhexidine. Swabs from both 
anterior nares were obtained for culture. On day 
3, residents whose anterior nares cultures had 
grown S. aureus  underwent culture again from 
both anterior nares and also from axillary and 
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Table 1. Patient characteristics 
Mupirocin 
Patient Mupirocin plus 
characteristics alone chlorhexidine 
Sex (no,) 
Male 8 7 
Female 19 22 
Age (yr) 
Range 44-49 42-98 
Median 79 78 
Diabetes mellitus (no,) 
Insulin-dependent 3 2 
Non-insulin-dependent 2 2 
Positive S. aureus culture 
(no.) 
Gastric tube site 2 2 
Open wound 1 1 
Functional status (no.) 
Independent 2 3 
Some assistance 8 10 
Most assistance 15 13 
Confined to bed 2 3 
Room arrangement (no.) 
Semiprivate 23 22 
Ward 4 7 
S. aureus carriage 
MRSA 16 17 
MSSA 11 12 
groin regions. A third culture of the anterior 
nares was done on day 5 if the second nares 
culture failed to grow S. aureus .  Residents with 
two nares cultures growing S. aureus  were en- 
rolled in the study. 
Study protocol 
Enrolled residents were examined for open 
wounds and decubitus ulcers; these were cultured 
if present. Demographic data, including the resi- 
dents' functional status, were recorded. Residents 
were divided into two groups. Alternate residents 
were enrolled in each group. Residents in the first 
group were given mupirocin 2% ointment in 
polyethylene glycol base, applied to the anterior 
nares and any open wound that grew S. aureus  in 
culture twice daily for 5 days. Residents in the 
second group were given the same mupirocin 
treatment with the addition of a bath with chlor- 
hexidine daily for the first 3 days. Appropriate 
numbers of mupirocin ointment packages and 
sterile cotton-tipped applicators (and, for patients 
in the second group a bottle of chlorhexidine 
solution) were put in a plastic bag labeled with the 
resident's name and location. This plastic bag was 
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Table 2. Results of positive cultures for S. aureus 
Mupirocin alone* 
Time of culture Anterior nares Axilla Groins 
Mupirocin plus chlorhexidinet 
Anterior nares Axilla Groins 
Before treatment 27/27 0/27 3/27 29/29. 0/29 2/29 
1 day after 2/27 0/27 0/27 0/29 0/29 1/29 
1 week after 0/27 0/27 0/27 1/29 0/29 0/29 
4 weeks after 2/26 0/26 1/26 2/29 0/29 2/29 
8 weeks after 3/25 1/25 0/25 3/28 0/28 2/28 
12 weeks after 6/25 0/25 0/25 4/27 0/27 2/27 
*Two residents were discharged during follow-up. 
t-rwo residents died during follow-up. 
given to the responsible personnel to use for that 
resident. Posttreatment cultures of the anterior 
nares; axilla, groin and any open wounds were 
taken at 1 day, 1 week, 4 weeks, 8 weeks, and 12 
weeks after completion of treatment. 
Microbio logy 
Swabs were streaked on mannitol salt agar and 
incubated at 37 ° C for 48 hours. Mannitol- 
positive colonies were tested for coagulase. 
Coagulase-positive colonies were designated as 
S. aureus. All S. aureus isolates were tested for 
susceptibility to methicillin by the standard disk- 
diffusion test. 1° 
RESULTS 
Four nursing homes participated in this study. 
The S. aureus nasal carriage rates among resi- 
dents were 10.7%, 23.4%, 26.5%, and 34.1% in 
these four nursing homes. The average was 28.2% 
(59/209 residents). 
Twenty-nine residents were assigned to the first 
group and 30 were assigned to the secon d group. 
One resident in the first group died before treat- 
ment and one was discharged uring treatment. 
One resident in the second group was discharged 
before treatment. Data from 27 residents and 29 
residents, respectively, were therefore available 
for analysis. There were no side effects from 
mupirocin ointment or chlorhexidine baths. 
Table 1 shows characteristics of both groups, 
including sex distribution, age, number with 
diabetes mellitus, number with wound cultures 
positive for S. aureus, functional status, room 
assignment, and susceptibility of S. aureus iso- 
lates. These were comparable between groups. 
Table 2 shows the results of cultures for S. aureus. 
Few residents were colonized at the axilla and 
extremely few residents were colonized in the 
groins. Both regimens were effective in eradi- 
cating nasal carriage of S. aureus, but recoloniza- 
tion occurred in both groups. At 12 weeks after 
treatment, 24% (6/25) versus 15% (4/27) in 
the mupirocin and mupirocin plus chlorhexidine 
groups, respectively, were recolonized. In the first 
group, three isolates were MRSA and three were 
MSSA; in the second group, three were MRSA and 
one was MSSA. 
DISCUSSION 
Antimicrobial soaps containing various antisep- 
tics have been used in conjunction with topical or 
systemic antimicrobial regimens in attempts to 
eradicate S. aureus nasal carriage, without clearly 
demonstrated efficacy. 6 In our study of compa- 
rable groups of residents, the S. aureus nasal 
recolonization rate at 12 weeks was 24% in the 
mupirocin alone group versus 15% in the mu- 
pirocin plus chlorhexidine group. This finding was 
not statistically different for our small-sample 
size. We had hoped to study a much larger 
population; however, we were  unable to recruit 
more nursing homes to participate in our study. To 
show statistical significance with a difference of 
this proportion, we would have needed to enroll 
almost 400 residents in each group. 
The efficacy of short-term application of mu- 
pirocin ointment in the eradication of S. aureus 
nasal carriage was again demonstrated in our 
study. The S. aureus nasal recolonization rate at 12 
weeks was quite low in both mupirocin-treated 
groups. Although the long-term use of mupirocin 
ointment has been associated with the develop- 
ment of mupirocin-resistant s rains of MRSA, s 
short-term use is much less likely to do so. A 
complete infection control program incorporating 
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many components  i clearly needed for the control 
of MRSA in long-term care facilities as well as 
acute care hospitals. 11,12 
We thank SrnithKline Beecham, King of Prussia, Pennsylvania, 
for providing the mupirocin 2% ointment and Stuart Pharma- 
ceuticals, Wilmington, Delaware, for providing the chlorhexi- 
dine solution. 
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